Related Experiment Video
Updated: Jun 1, 2025

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides
Published on: September 16, 2020
Mitochondrial Localization of Antioxidant Nanodrug Suppresses Ocular Inflammation by Alleviating Oxidative Stress on
Zhibin Ren1, Xiaoying Liu1, Guanghao Lv1
1National Engineering Research Center of Ophthalmology and Optometry, School of Ophthalmology and Optometry & Biomedical Engineering, Eye Hospital, Wenzhou Medical University, 270 Xueyuan Road, Wenzhou, 325027, China.
Abstract:
External environments (e. g., pollutants, irritants, ultraviolet radiation, etc) probably activate oxidative stress on the ocular surface, further leading to inflammatory responses and cellular apoptosis. For treating ophthalmic diseases, one of the strategies is to regulate oxidative stress through antioxidants. Here we conjugate a polyphenolic antioxidant drug (i. e., caffeic acid) with a small peptide of protein tag to generate a peptide-drug conjugate as a nanodrug. With a self-assembled ability to form nanoparticles, the nanodrug mainly enters human corneal epithelial cells (HCEC) by caveolin-mediated endocytosis, succeeds lysosomal escape, and achieves mitochondrial localization of caffeic acid. Revealed by free radical scavenging experiments, the nanodrug shows considerable antioxidant capacities. In mouse leukemia cells of monocyte macrophage (RAW 264.7) induced by lipopolysaccharide (LPS), the nanodrug inhibits various pro-inflammatory cytokines (e. g., NO, IL-6, and TNF-α) by up-regulating the expression of anti-apoptotic protein (e. g., Bcl-2). As an investigation of alleviating oxidative stress by the mitochondrial localization of antioxidant, this work may establish an experimental foundation for the regulation of cellular redox balance, as well as provide different insights for the clinical development of antioxidant drug delivery systems in the treatment of ocular disease.
Insights
This study developed a novel nanodrug by conjugating caffeic acid with a peptide. The nanodrug effectively delivers antioxidants to cells, reducing oxidative stress and inflammation for potential ophthalmic disease treatment.
Area of Science:
- Ocular Surface Science
- Nanomedicine
- Cellular Biology
Background:
- External environmental factors induce oxidative stress on the ocular surface, leading to inflammation and apoptosis.
- Antioxidants are a key strategy for managing oxidative stress in ophthalmic diseases.
- Developing effective drug delivery systems is crucial for ocular therapeutics.
Purpose of the Study:
- To create a peptide-drug conjugate nanodrug for targeted antioxidant delivery.
- To investigate the cellular uptake, localization, and antioxidant efficacy of the nanodrug.
- To evaluate the nanodrug's potential in mitigating inflammation and promoting cell survival.
Main Methods:
- Conjugation of caffeic acid (polyphenolic antioxidant) with a peptide tag to form a self-assembling nanodrug.
- Characterization of nanodrug uptake via caveolin-mediated endocytosis in human corneal epithelial cells (HCEC).
- Assessment of antioxidant capacity through free radical scavenging and anti-inflammatory effects in lipopolysaccharide (LPS)-induced RAW 264.7 cells.
Main Results:
- The nanodrug successfully localized caffeic acid within mitochondria after lysosomal escape.
- Significant free radical scavenging activity was demonstrated by the nanodrug.
- The nanodrug inhibited pro-inflammatory cytokines (NO, IL-6, TNF-α) and upregulated anti-apoptotic protein Bcl-2 in LPS-stimulated cells.
Conclusions:
- Mitochondrial localization of antioxidants via this nanodrug effectively alleviates cellular oxidative stress.
- The nanodrug demonstrates potential for regulating cellular redox balance and treating ocular diseases.
- This approach offers novel insights for developing antioxidant drug delivery systems for clinical applications.
More Related Videos
14:25Quantification of Reactive Oxygen Species Using 2′,7′-Dichlorofluorescein Diacetate Probe and Flow-Cytometry in Müller Glial Cells
Published on: May 13, 2022
06:50Author Spotlight: Bidirectional Mitochondrial Transfer between MSCs and Retinal Pigment Epithelium Cells — Pathways and In Vivo Challenges
Published on: October 4, 2024
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...